[Vascular endothelial growth factor therapy in ischaemic heart disease].
Ugeskr Laeger
; 182(44)2020 10 26.
Article
en Da
| MEDLINE
| ID: mdl-33118488
Atherosclerosis of coronary arteries can result in a hypoxic state where myocardial cells may become dysfunctional or die. The oxygen sensing transcription factor hypoxia inducible factor 1 responds to low oxygen levels by elevating the production of angiogenic growth factors, such as vascular endothelial growth factor (VEGF). Despite this, endogenous processes and conventional therapies are inefficient in some patients. To stimulate angiogenesis, VEGF has been injected into the myocardium. As stated in this review, this therapy has so far been proven safe and studies are conducted in several countries, including Denmark.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Isquemia Miocárdica
/
Factor A de Crecimiento Endotelial Vascular
Límite:
Humans
Idioma:
Da
Revista:
Ugeskr Laeger
Año:
2020
Tipo del documento:
Article
Pais de publicación:
Dinamarca